WRBY - Warby Parker Inc.

Insider Sale by Blumenthal Neil Harris (Co-CEO)

1 Month
After Trade
Before Trade

Loading data...

Trade Summary

5 days ago, Blumenthal Neil Harris, serving as Co-CEO at Warby Parker Inc. (WRBY), sold 100,000 shares at $24.67 per share, for a total transaction value of $2,467,130.00. Following this transaction, Blumenthal Neil Harris now holds 450,165 shares of WRBY.

This sale represents a 18.00% decrease in Blumenthal Neil Harris's stake in the company. This is considered a high-conviction trade given the significant change in ownership.

The trade was executed on Thursday, April 16, 2026 and publicly disclosed via SEC Form 4 filing on Monday, April 20, 2026, 4 days after the trade was made.

Warby Parker Inc. operates in the HEALTHCARE sector, specifically within the MEDICAL INSTRUMENTS & SUPPLIES industry. Insider selling activity in this sector can provide valuable signals about industry trends and company-specific developments.

Blumenthal Neil Harris

Co-CEO

Neil Harris Blumenthal is the co-founder and Co-CEO of Warby Parker Inc. (NYSE: WRBY), a direct-to-consumer eyewear company he launched in 2010 alongside Dave Gilboa, Andrew Hunt, and Jeffrey Raider while attending business school.[[1]](https://lattice.com/podcasts/neil-blumenthal)[[2]](https://www.marketbeat.com/instant-alerts/warby-parker-nysewrby-ceo-sells-135400000-in-stock-2026-01-09/) Prior to Warby Parker, Blumenthal served as director of VisionSpring, a nonprofit that trained women in developing countries to sell affordable eyeglasses, experiences that informed Warby Parker's mission to offer designer eyewear at reduced prices ($95 frames) and incorporate social good, such as donating glasses through 'Buy a Pair, Give a Pair.'[[1]](https://lattice.com/podcasts/neil-blumenthal)[[2]](https://www.marketbeat.com/instant-alerts/warby-parker-nysewrby-ceo-sells-135400000-in-stock-2026-01-09/) Under his leadership, the company grew to nearly 3,000 employees, over 140 stores across the US and Canada, and facilities including headquarters in New York and Nashville, plus an optical lab; it was named the most innovative company by Fast Company in 2015.[[1]](https://lattice.com/podcasts/neil-blumenthal) Blumenthal, a Wharton School graduate, continues as Co-CEO, sharing responsibilities with Gilboa through structured division of departments and frequent communication to scale effectively.[[1]](https://lattice.com/podcasts/neil-blumenthal) Recently, as of January 2026, he sold shares including 50,000 on January 7 at $27.08 (totaling $1.354 million), 150,000 on January 6, and 100,000 on December 11, reducing direct Class A ownership to 37,119 shares while retaining significant Class B holdings and indirect stakes via family trusts.[[2]](https://www.marketbeat.com/instant-alerts/warby-parker-nysewrby-ceo-sells-135400000-in-stock-2026-01-09/)[[3]](https://www.investing.com/news/insider-trading-news/warby-parkers-blumenthal-sells-135m-in-shares-93CH-4440506)[[4]](https://longbridge.com/en/news/272137007)

View full insider profile →

Trade Price

$24.67

Quantity

100,000

Total Value

$2,467,130.00

Shares Owned

450,165

Trade Date

Thursday, April 16, 2026

5 days ago

SEC Filing Date

Monday, April 20, 2026

Filed 4 days after trade

HEALTHCAREMEDICAL INSTRUMENTS & SUPPLIES

About Warby Parker Inc.

Company Overview

No company information available
View news mentioning WRBY

💬 Want Deeper Insight?

Use our AI assistant to ask questions about this trade, the insider, or the company.

Chat with AI

Share this trade

https://insidersignal.ai/trade/5811243

🚀 Track Insider Trades in Real-Time

Create a free account to access our full database of insider trades, AI-powered analysis, price alerts, and discover what corporate executives are buying and selling.

✓ Free forever plan available  •  ✓ No credit card required  •  ✓ Cancel anytime